Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure
about
Cardiopulmonary laboratory biomarkers in the evaluation of acute dyspneaUnderstanding heart failure with preserved ejection fraction: where are we today?Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Cardiovascular and Cerebrovascular DiseasesCXCL10 Is a Circulating Inflammatory Marker in Patients with Advanced Heart Failure: a Pilot Study.Diagnostic Accuracy of NT-ProBNP for Heart Failure with Sepsis in Patients Younger than 18 YearsN-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.The influence of body composition on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with acute coronary syndrome: a cohort study.Heat-killed Lactobacillus Reuteri GMNL-263 Prevents Epididymal Fat Accumulation and Cardiac Injury in High-Calorie Diet-Fed Rats.How peptide technology has improved costs and outcomes in patients with heart failure.Oxidative stress and inflammatory markers - the future of heart failure diagnostics?Rationales and choices for the treatment of patients with NYHA class II heart failure.Short term variation in NTproBNP after lifestyle intervention in severe obesity.Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction.NTproBNP in insulin-resistance mediated conditions: overweight/obesity, metabolic syndrome and diabetes. The population-based Casale Monferrato StudyDifferential expression of B-type natriuretic peptide between left and right ventricles, with particular regard to sudden cardiac death.Gene expression and gene associations during the development of heart failure with preserved ejection fraction in the Dahl salt sensitive model of hypertension.NT-proBNP test with improved accuracy for the diagnosis of chronic heart failure.Evaluation of cardiovascular disease risk in women with surgically induced menopause.Protective effects of recombinant human brain natriuretic peptide in perioperative period during open heart surgery.Point-of-care B-type natriuretic peptide and portable echocardiography for assessment of patients with suspected heart failure in primary care: rationale and design of the three-part Handheld-BNP program and results of the training study.Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Dec[The new ESC Guidelines for acute and chronic heart failure 2016].Echo and heart failure: when do people need an echo, and when do they need natriuretic peptides?Association of brain natriuretic peptide gene polymorphisms with chronic obstructive pulmonary disease complicated with pulmonary hypertension and its mechanismThe Association between Antihypertensive Medication Use and Blood Pressure Is Influenced by ObesityMidregional pro-atrial natriuretic peptide is a superior biomarker to N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure patients with preserved ejection fraction
P2860
Q26745756-3B8BECBC-2BBD-44C0-9D0D-0BF71E79050EQ26766590-CD9963B5-86C0-4798-97C0-688F6EFAC876Q26800274-CDC0E78C-3972-4B22-9027-FBE7B377AE6EQ34529921-4BA648F1-5D1D-4B81-B8B5-F2E611D5E7A6Q35905091-1E1D5BE2-6B89-4A31-81C6-A358A25DCDDCQ36593924-2C247688-477D-447E-AE63-92862CE2906FQ36769441-2FBE3CD3-4D86-4C14-A3E5-80C854F7EE75Q37154423-859C5281-AD81-4E3A-9A90-8B803754368CQ38830022-6D6D6D93-9EE4-4A5B-87D1-39DCD64905ADQ38967724-230A8400-546D-41EB-8392-09E42DB727B8Q39410727-F39FD4C2-485B-4E31-94A9-B0BC06DB78E4Q41007414-245793F2-6AD3-4EE6-962A-816CBECE97C6Q41025346-151F15E7-108B-49F2-9E8C-9464A7BE6F2CQ42363898-2AEEB564-0F51-47CB-BB6A-9B98BD53E12DQ42679244-9FF66A21-CDE7-4FDF-97B4-1B8A9786EAA5Q47400069-E8A016E1-8013-44E4-9EA6-6424205B1EB0Q47825830-BC0B5B3C-CB00-4048-A40D-03084D3CC925Q48955313-AF664840-BAE6-470A-AD9A-9E6A82C3459FQ49875457-B80500E1-AA57-4911-BD77-CC02580E0FE3Q49977772-54C041D8-66AA-4258-8084-5F2B784FDA00Q50069569-3FBDE573-D53B-4B4D-B68A-2D04F580B6B0Q52844963-82C5623E-D6CF-45F2-B366-F7E4AF43F525Q55346961-7CB384D0-F3C4-4344-B2A8-B327B2A5C25AQ57044351-6B0818B5-D492-43EE-80D1-68E579A6503FQ58595947-633D244D-9C7C-489D-80BA-93B43B8586FAQ58759117-A38D2772-548C-4413-A347-5B00B1D4B88C
P2860
Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Obesity and natriuretic peptid ...... implications for heart failure
@ast
Obesity and natriuretic peptid ...... implications for heart failure
@en
Obesity and natriuretic peptid ...... implications for heart failure
@nl
type
label
Obesity and natriuretic peptid ...... implications for heart failure
@ast
Obesity and natriuretic peptid ...... implications for heart failure
@en
Obesity and natriuretic peptid ...... implications for heart failure
@nl
prefLabel
Obesity and natriuretic peptid ...... implications for heart failure
@ast
Obesity and natriuretic peptid ...... implications for heart failure
@en
Obesity and natriuretic peptid ...... implications for heart failure
@nl
P2093
P2860
P921
P3181
P1476
Obesity and natriuretic peptid ...... implications for heart failure
@en
P2093
Arihiro Sumida
Chaitanya Madamanchi
Hassan Alhosaini
Marschall S. Runge
P2860
P3181
P356
10.1016/J.IJCARD.2014.08.007
P407
P577
2014-10-20T00:00:00Z